Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans.

CD3 + , CD8 + T lymphocytes and total CD56 + NK cells were reduced, but differences did not reach statistical significance ( Figure S1A–C ).

also in 111,027 other papers